The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
NSAID API-Global Market Insights and Sales Trends 2024
Synopsis
Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects.
The global NSAID API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of NSAID API in various end use industries. The expanding demands from the Captive Manufacturing and Contract Manufacturing, are propelling NSAID API market. Paracetamol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ibuprofen segment is estimated at % CAGR for the next seven-year period.
North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for NSAID API, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global NSAID API market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global NSAID API market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, NSAID API sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of NSAID API covered in this report include Novartis, Pfizer, Boehringer Ingelheim, Teva Pharmaceutical, BASF, Hospira, Lonza Group, Mylan and Aurobindo Pharma, etc.
The global NSAID API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Pfizer
Boehringer Ingelheim
Teva Pharmaceutical
BASF
Hospira
Lonza Group
Mylan
Aurobindo Pharma
Cambrex
Dr. Reddy's Laboratories
Actavis
Wuxi Apptec
Zhejiang NHU
Global NSAID API market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global NSAID API market, Segment by Type:
Paracetamol
Ibuprofen
Aspirin
Naproxen
Others
Global NSAID API market, by Application
Captive Manufacturing
Contract Manufacturing
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of NSAID API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of NSAID API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects.
The global NSAID API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of NSAID API in various end use industries. The expanding demands from the Captive Manufacturing and Contract Manufacturing, are propelling NSAID API market. Paracetamol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ibuprofen segment is estimated at % CAGR for the next seven-year period.
North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for NSAID API, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global NSAID API market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global NSAID API market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, NSAID API sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of NSAID API covered in this report include Novartis, Pfizer, Boehringer Ingelheim, Teva Pharmaceutical, BASF, Hospira, Lonza Group, Mylan and Aurobindo Pharma, etc.
The global NSAID API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Pfizer
Boehringer Ingelheim
Teva Pharmaceutical
BASF
Hospira
Lonza Group
Mylan
Aurobindo Pharma
Cambrex
Dr. Reddy's Laboratories
Actavis
Wuxi Apptec
Zhejiang NHU
Global NSAID API market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global NSAID API market, Segment by Type:
Paracetamol
Ibuprofen
Aspirin
Naproxen
Others
Global NSAID API market, by Application
Captive Manufacturing
Contract Manufacturing
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of NSAID API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of NSAID API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 NSAID API Market Overview
1.1 NSAID API Product Overview
1.2 NSAID API Market Segment by Type
1.2.1 Paracetamol
1.2.2 Ibuprofen
1.2.3 Aspirin
1.2.4 Naproxen
1.2.5 Others
1.3 Global NSAID API Market Size by Type
1.3.1 Global NSAID API Market Size Overview by Type (2018-2029)
1.3.2 Global NSAID API Historic Market Size Review by Type (2018-2023)
1.3.3 Global NSAID API Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America NSAID API Sales Breakdown by Type (2018-2023)
1.4.2 Europe NSAID API Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific NSAID API Sales Breakdown by Type (2018-2023)
1.4.4 Latin America NSAID API Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa NSAID API Sales Breakdown by Type (2018-2023)
2 Global NSAID API Market Competition by Company
2.1 Global Top Players by NSAID API Sales (2018-2023)
2.2 Global Top Players by NSAID API Revenue (2018-2023)
2.3 Global Top Players by NSAID API Price (2018-2023)
2.4 Global Top Manufacturers NSAID API Manufacturing Base Distribution, Sales Area, Product Type
2.5 NSAID API Market Competitive Situation and Trends
2.5.1 NSAID API Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by NSAID API Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NSAID API as of 2022)
2.7 Date of Key Manufacturers Enter into NSAID API Market
2.8 Key Manufacturers NSAID API Product Offered
2.9 Mergers & Acquisitions, Expansion
3 NSAID API Status and Outlook by Region
3.1 Global NSAID API Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global NSAID API Historic Market Size by Region
3.2.1 Global NSAID API Sales in Volume by Region (2018-2023)
3.2.2 Global NSAID API Sales in Value by Region (2018-2023)
3.2.3 Global NSAID API Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global NSAID API Forecasted Market Size by Region
3.3.1 Global NSAID API Sales in Volume by Region (2024-2029)
3.3.2 Global NSAID API Sales in Value by Region (2024-2029)
3.3.3 Global NSAID API Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global NSAID API by Application
4.1 NSAID API Market Segment by Application
4.1.1 Captive Manufacturing
4.1.2 Contract Manufacturing
4.2 Global NSAID API Market Size by Application
4.2.1 Global NSAID API Market Size Overview by Application (2018-2029)
4.2.2 Global NSAID API Historic Market Size Review by Application (2018-2023)
4.2.3 Global NSAID API Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America NSAID API Sales Breakdown by Application (2018-2023)
4.3.2 Europe NSAID API Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific NSAID API Sales Breakdown by Application (2018-2023)
4.3.4 Latin America NSAID API Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa NSAID API Sales Breakdown by Application (2018-2023)
5 North America NSAID API by Country
5.1 North America NSAID API Historic Market Size by Country
5.1.1 North America NSAID API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America NSAID API Sales in Volume by Country (2018-2023)
5.1.3 North America NSAID API Sales in Value by Country (2018-2023)
5.2 North America NSAID API Forecasted Market Size by Country
5.2.1 North America NSAID API Sales in Volume by Country (2024-2029)
5.2.2 North America NSAID API Sales in Value by Country (2024-2029)
6 Europe NSAID API by Country
6.1 Europe NSAID API Historic Market Size by Country
6.1.1 Europe NSAID API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe NSAID API Sales in Volume by Country (2018-2023)
6.1.3 Europe NSAID API Sales in Value by Country (2018-2023)
6.2 Europe NSAID API Forecasted Market Size by Country
6.2.1 Europe NSAID API Sales in Volume by Country (2024-2029)
6.2.2 Europe NSAID API Sales in Value by Country (2024-2029)
7 Asia-Pacific NSAID API by Region
7.1 Asia-Pacific NSAID API Historic Market Size by Region
7.1.1 Asia-Pacific NSAID API Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific NSAID API Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific NSAID API Sales in Value by Region (2018-2023)
7.2 Asia-Pacific NSAID API Forecasted Market Size by Region
7.2.1 Asia-Pacific NSAID API Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific NSAID API Sales in Value by Region (2024-2029)
8 Latin America NSAID API by Country
8.1 Latin America NSAID API Historic Market Size by Country
8.1.1 Latin America NSAID API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America NSAID API Sales in Volume by Country (2018-2023)
8.1.3 Latin America NSAID API Sales in Value by Country (2018-2023)
8.2 Latin America NSAID API Forecasted Market Size by Country
8.2.1 Latin America NSAID API Sales in Volume by Country (2024-2029)
8.2.2 Latin America NSAID API Sales in Value by Country (2024-2029)
9 Middle East and Africa NSAID API by Country
9.1 Middle East and Africa NSAID API Historic Market Size by Country
9.1.1 Middle East and Africa NSAID API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa NSAID API Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa NSAID API Sales in Value by Country (2018-2023)
9.2 Middle East and Africa NSAID API Forecasted Market Size by Country
9.2.1 Middle East and Africa NSAID API Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa NSAID API Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis NSAID API Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novartis NSAID API Products Offered
10.1.5 Novartis Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer NSAID API Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pfizer NSAID API Products Offered
10.2.5 Pfizer Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim NSAID API Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Boehringer Ingelheim NSAID API Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Teva Pharmaceutical
10.4.1 Teva Pharmaceutical Company Information
10.4.2 Teva Pharmaceutical Introduction and Business Overview
10.4.3 Teva Pharmaceutical NSAID API Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Teva Pharmaceutical NSAID API Products Offered
10.4.5 Teva Pharmaceutical Recent Development
10.5 BASF
10.5.1 BASF Company Information
10.5.2 BASF Introduction and Business Overview
10.5.3 BASF NSAID API Sales, Revenue and Gross Margin (2018-2023)
10.5.4 BASF NSAID API Products Offered
10.5.5 BASF Recent Development
10.6 Hospira
10.6.1 Hospira Company Information
10.6.2 Hospira Introduction and Business Overview
10.6.3 Hospira NSAID API Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Hospira NSAID API Products Offered
10.6.5 Hospira Recent Development
10.7 Lonza Group
10.7.1 Lonza Group Company Information
10.7.2 Lonza Group Introduction and Business Overview
10.7.3 Lonza Group NSAID API Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Lonza Group NSAID API Products Offered
10.7.5 Lonza Group Recent Development
10.8 Mylan
10.8.1 Mylan Company Information
10.8.2 Mylan Introduction and Business Overview
10.8.3 Mylan NSAID API Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Mylan NSAID API Products Offered
10.8.5 Mylan Recent Development
10.9 Aurobindo Pharma
10.9.1 Aurobindo Pharma Company Information
10.9.2 Aurobindo Pharma Introduction and Business Overview
10.9.3 Aurobindo Pharma NSAID API Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Aurobindo Pharma NSAID API Products Offered
10.9.5 Aurobindo Pharma Recent Development
10.10 Cambrex
10.10.1 Cambrex Company Information
10.10.2 Cambrex Introduction and Business Overview
10.10.3 Cambrex NSAID API Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Cambrex NSAID API Products Offered
10.10.5 Cambrex Recent Development
10.11 Dr. Reddy's Laboratories
10.11.1 Dr. Reddy's Laboratories Company Information
10.11.2 Dr. Reddy's Laboratories Introduction and Business Overview
10.11.3 Dr. Reddy's Laboratories NSAID API Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Dr. Reddy's Laboratories NSAID API Products Offered
10.11.5 Dr. Reddy's Laboratories Recent Development
10.12 Actavis
10.12.1 Actavis Company Information
10.12.2 Actavis Introduction and Business Overview
10.12.3 Actavis NSAID API Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Actavis NSAID API Products Offered
10.12.5 Actavis Recent Development
10.13 Wuxi Apptec
10.13.1 Wuxi Apptec Company Information
10.13.2 Wuxi Apptec Introduction and Business Overview
10.13.3 Wuxi Apptec NSAID API Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Wuxi Apptec NSAID API Products Offered
10.13.5 Wuxi Apptec Recent Development
10.14 Zhejiang NHU
10.14.1 Zhejiang NHU Company Information
10.14.2 Zhejiang NHU Introduction and Business Overview
10.14.3 Zhejiang NHU NSAID API Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Zhejiang NHU NSAID API Products Offered
10.14.5 Zhejiang NHU Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 NSAID API Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 NSAID API Industrial Chain Analysis
11.4 NSAID API Market Dynamics
11.4.1 NSAID API Industry Trends
11.4.2 NSAID API Market Drivers
11.4.3 NSAID API Market Challenges
11.4.4 NSAID API Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 NSAID API Distributors
12.3 NSAID API Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
